172 related articles for article (PubMed ID: 25014125)
1. Computational predictions of glass-forming ability and crystallization tendency of drug molecules.
Alhalaweh A; Alzghoul A; Kaialy W; Mahlin D; Bergström CA
Mol Pharm; 2014 Sep; 11(9):3123-32. PubMed ID: 25014125
[TBL] [Abstract][Full Text] [Related]
2. Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development.
Mahlin D; Ponnambalam S; Höckerfelt MH; Bergström CA
Mol Pharm; 2011 Apr; 8(2):498-506. PubMed ID: 21344945
[TBL] [Abstract][Full Text] [Related]
3. Early drug development predictions of glass-forming ability and physical stability of drugs.
Mahlin D; Bergström CA
Eur J Pharm Sci; 2013 May; 49(2):323-32. PubMed ID: 23557841
[TBL] [Abstract][Full Text] [Related]
4. Is there a correlation between the glass forming ability of a drug and its supersaturation propensity?
Blaabjerg LI; Lindenberg E; Löbmann K; Grohganz H; Rades T
Int J Pharm; 2018 Mar; 538(1-2):243-249. PubMed ID: 29341914
[TBL] [Abstract][Full Text] [Related]
5. Glass-forming ability of compounds in marketed amorphous drug products.
Wyttenbach N; Kuentz M
Eur J Pharm Biopharm; 2017 Mar; 112():204-208. PubMed ID: 27903457
[TBL] [Abstract][Full Text] [Related]
6. A classification system to assess the crystallization tendency of organic molecules from undercooled melts.
Baird JA; Van Eerdenbrugh B; Taylor LS
J Pharm Sci; 2010 Sep; 99(9):3787-806. PubMed ID: 20623696
[TBL] [Abstract][Full Text] [Related]
7. Theoretical Considerations of the Prigogine-Defay Ratio with Regard to the Glass-Forming Ability of Drugs from Undercooled Melts.
Wyttenbach N; Kirchmeyer W; Alsenz J; Kuentz M
Mol Pharm; 2016 Jan; 13(1):241-50. PubMed ID: 26587865
[TBL] [Abstract][Full Text] [Related]
8. Predicting Glass-Forming Ability of Pharmaceutical Compounds by Using Machine Learning Technologies.
Jiang J; Ouyang D; Williams RO
AAPS PharmSciTech; 2023 Apr; 24(5):103. PubMed ID: 37072563
[TBL] [Abstract][Full Text] [Related]
9. Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.
Kawakami K; Usui T; Hattori M
J Pharm Sci; 2012 Sep; 101(9):3239-48. PubMed ID: 22531946
[TBL] [Abstract][Full Text] [Related]
10. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
[TBL] [Abstract][Full Text] [Related]
11. Molecular Drivers of Crystallization Kinetics for Drugs in Supersaturated Aqueous Solutions.
Alhalaweh A; Alzghoul A; Bergström CAS
J Pharm Sci; 2019 Jan; 108(1):252-259. PubMed ID: 30423342
[TBL] [Abstract][Full Text] [Related]
12. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
13. Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability.
Alhalaweh A; Alzghoul A; Mahlin D; Bergström CAS
Int J Pharm; 2015 Nov; 495(1):312-317. PubMed ID: 26341321
[TBL] [Abstract][Full Text] [Related]
14. Influence of preparation pathway on the glass forming ability.
Blaabjerg LI; Lindenberg E; Rades T; Grohganz H; Löbmann K
Int J Pharm; 2017 Apr; 521(1-2):232-238. PubMed ID: 28232267
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured Parameters.
Nurzyńska K; Booth J; Roberts CJ; McCabe J; Dryden I; Fischer PM
Mol Pharm; 2015 Sep; 12(9):3389-98. PubMed ID: 26236939
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
[TBL] [Abstract][Full Text] [Related]
17. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
18. Impact of Intermolecular Interactions, Dimeric Structures on the Glass Forming Ability of Naproxen, and a Series of Its Derivatives.
Minecka A; Kaminska E; Tarnacka M; Grudzka-Flak I; Bartoszek M; Wolnica K; Dulski M; Kaminski K; Paluch M
Mol Pharm; 2018 Oct; 15(10):4764-4776. PubMed ID: 30156420
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Physical (In)Stability of Spray-Dried Amorphous Drugs: Relationship with Glass-Forming Ability and Physicochemical Properties.
Edueng K; Bergström CAS; Gråsjö J; Mahlin D
Pharmaceutics; 2019 Aug; 11(9):. PubMed ID: 31438566
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pH-dependent aqueous solubility of druglike molecules.
Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
